Although the vast majority of nodules are benign, many are referred for biopsy as a precaution to rule out malignancy.

The company seeks to “organize the world’s medical images,” serving as a data marketplace for biopharma firms, researchers, physicians and AI companies.  

The duo announced the partnership on Monday, stating that the collaboration marks “a shift in how healthcare institutions approach data.” 

New data suggest the model outperforms publicly available segmentation algorithms.  

A U.S. military contractor has agreed to an $11.2 million settlement with the U.S. Department of Justice to resolve allegations it lied about properly securing sensitive patient data tied to the Tricare program.

Hacker group Medusa claimed responsibility for the cyberattack on its blog, according to a report published Tuesday. 

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated? 

Though numerous web-based tools have been created to flag published works that appear suspicious for AI authorship, the performances of these tools has been inconsistent thus far.